Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

cbdMD (YCBD) EBITDA Margin (2016 - 2025)

cbdMD (YCBD) has disclosed EBITDA Margin for 10 consecutive years, with 5.71% as the latest value for Q4 2025.

  • Quarterly EBITDA Margin fell 402.0% to 5.71% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 12.37% through Dec 2025, down 75.0% year-over-year, with the annual reading at 11.27% for FY2025, 537.0% up from the prior year.
  • EBITDA Margin hit 5.71% in Q4 2025 for cbdMD, up from 14.53% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 1.69% in Q4 2024 to a low of 373.55% in Q2 2022.
  • Historically, EBITDA Margin has averaged 77.78% across 5 years, with a median of 30.21% in 2023.
  • Biggest five-year swings in EBITDA Margin: plummeted -31034bps in 2022 and later soared 34533bps in 2023.
  • Year by year, EBITDA Margin stood at 269.74% in 2021, then surged by 76bps to 64.84% in 2022, then skyrocketed by 69bps to 19.83% in 2023, then soared by 91bps to 1.69% in 2024, then plummeted by -238bps to 5.71% in 2025.
  • Business Quant data shows EBITDA Margin for YCBD at 5.71% in Q4 2025, 14.53% in Q3 2025, and 19.64% in Q2 2025.